C0066563||Mineralocorticoid Receptor
C3540676||Blockade
C0403592||Chronic Kidney Allograft Nephropathy
C0066563||mineralocorticoid receptor
C3540676||blockade
C3540676||MRB)
C3875332||chronic cyclosporine nephropathy
C3875332||CsA-Nx
C0034693||rat
C3494163||translational study
C0961485||eplerenone
C1533734||administration
C0564454||renal allograft
C0005558||biopsy
C0403592||chronic allograft nephropathy
C0403592||chronic allograft nephropathy
C0022671||Renal transplant
C0005558||biopsy
C0403592||chronic allograft nephropathy
C0017654||GFR
C0005670||BK virus
C0027697||nephritis
C0022658||renal disease
C0853068||GFR decline
C0332293||treated with
C0006684||calcium antagonists
C0003308||antifungal drugs
C0032042||placebo
C0961485||eplerenone
C0178913||blood
C1610733||urine samples
C1318439||Urine creatinine
C0050092||8-hydroxylated-guanosine
C0256926||heat shock protein 72
C0256926||heat shock protein 72
C2681921||kidney injury molecule (KIM-1) levels
C0586763||kidney biopsy samples
C4285457||tubulo-interstitial area affected by fibrosis
C4285457||TIF
C0178664||glomerulosclerosis
C0017654||eGFR
C1257890||placebo
C1257890||eplerenone group
C1318293||albumin-to-creatinine ratio
C1257890||placebo
C1257890||eplerenone group
C0032042||placebo
C4285457||TIF
C0178664||glomerulosclerosis
C0042036||urinary
C0256926||heat shock protein 72
C2603343||study
C0961485||eplerenone
C1533734||administration
C0403592||chronic allograft nephropathy
C3540676||mineralocorticoid receptor blockade
C1257890||pediatric population